Diagnostic Biosystems is a leading developer of specialty Immunohistochemistry reagents. The company is dedicated to high quality antibody production and development of novel multiplex staining reagents. Building on its strong global presence, Diagnostic Biosystems produces novel, clinically relevant tools for pathology market including: monoclonal and polyclonal antibodies, a wide range of detection systems and ancillary reagents for high quality immunostaining. Custom Monoclonal and Polyclonal Antibody Production Services include peptide synthesis, in vitro and in vivo antibody production, purification and conjugation.
Diagnostic BioSystems is an FDA registered medical device manufacturer, operating under FDA 21CFR Part 820 Quality System Regulations and certified under ISO 9001:2000 Quality Management System International standards, manufacturing CE marked medical devices, for use in the European market.
Specialties
DBS specializes in a development IVD labeled immunostaining reagents suitable for manual and automated Immunohistochemistry staining platforms.
Diagnostic Biosystems Activity on LinkedIn
-
Diagnostic Biosystems has a new Sales Administrator
Kuren Gupta is now Sales Administrator, was Demand Generation Executive at Aryaka Networks
